Logo-jcvtr

J Cardiovasc Thorac Res. 2019;11(1): 14-18. doi: 10.15171/jcvtr.2019.03
PMID: 31024667        PMCID: PMC6477114

Original Article

Utility of N-terminal pro-brain natriuretic peptide in detecting diastolic dysfunction in asymptomatic hypertensive patients: comparison with echocardiography

Sahadeb Prasad Dhungana 1 * , Prahlad Karki 1, Madhab Lamsal 2

Cited by CrossRef: 2


1- Andreasova T, Malek F, Zakostelska-Jiraskova Z, Neuzil P, Vranova J. Association of biomarkers of cardiac remodeling, myocardial fibrosis and inflammation with parameters of heart function and structure in patients with arterial hypertension. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024; [Crossref]
2- Dai W, Liu Y, Yao F, Li W, Liu J, Li C, Liu D, Hu K. Syndecan-4 is More Sensitive in Detecting Hypertensive Left Ventricular Diastolic Dysfunction in 2K2C Rats. International Journal of Hypertension. 2022;2022:1 [Crossref]
3- Nikolaev K, Shilova A, Kovaleva A, Lifshits G. Role of brain natriuretic peptide in the pathogenesis of resistant hypertension. Russ J Cardiol. 2022;28(1):5188 [Crossref]
4- Badiger S, Hanumappa V, Jugati A. A Study of Tpeak-Tend/QT Interval Ratio in Predicting Heart Failure in ST-Elevation Myocardial Infarction and Its Correlation With N-terminal Pro B-type Natriuretic Peptide (NT-proBNP). 2024; [Crossref]